Hebei Rimao Technology
Tirzepatide
Finnrick tested 3 samples of Tirzepatide (GLP-1 and GIP agonist) from Hebei Rimao Technology between 30 Sep 2025 and 24 Oct 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Hebei Rimao Technology
Tirzepatide
Tested 3 Samples
Last test 24 Oct 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Tirzepatide tests from top-rated vendors:
All Tirzepatide tests from Hebei Rimao Technology
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
24 Oct 2025
First
30 Sep 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 24 Oct 2025 | View | 60mg | 62.31mg | +3.9% | 99.90% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 30 Sep 2025 | View | 20mg | 9.67mg | -51.6% | 99.74% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 30 Sep 2025 | View | 60mg | 58.1mg | -3.2% | 99.95% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |